Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Abstract
Excess free iron generates oxidative stress that hallmarks diseases of aging. The observation that patients with Alzheimer's disease or Parkinson's disease show a dramatic increase in their brain iron content has opened the possibility that disturbances in brain iron homeostasis may contribute to the pathogenesis of these disorders. While the reason for iron accumulation is unknown, iron localization correlates with the production of reactive oxygen species in those areas of the brain that are prone to neurodegeneration. A role for iron is also proposed in atherosclerosis, a further frequent disorder of aging. We will review experimental evidences for an involvement of iron in these diseases and discuss some mouse models with impairment in iron-related genes that may be useful to study the role of iron in these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron chelation improves endothelial function”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Altamura and Muckenthaler 2009
In the citing paper
“Excessive amounts of total iron will decrease furin activity because transcription of furin is modulated by cellular concentrations of iron, leading to decreased furin protein concentrations which thereby favours β secretase activity and enhances the amyloidogenic pathway.”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
In the citing paper
“By contrast, iron deficiency will increase furin activity, thereby enhancing α secretase and stimulating the non-amyloidogenic pathway.78,80”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
In the citing paper
“APP translation might therefore be up-regulated in conditions of iron excess, increasing the amount of APP available to enter the amyloidgenic pathway, which is favoured by decreased furin activity.78”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630 · cited 1×
“Atherosclerosis can be initiated by the injury of endothelial cells of the arterial wall that leads to enhanced permeability [121].”
BackgroundMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 1×
“In 96% of cases, it is caused by a GAA nucleotide repeat expansion inside the first intron of the frataxin gene resulting in reduced frataxin mRNA expression [183].”
Background
Cited by
Items 101–200 of 378
Kumar, V., Mohan, S., Singh, D. K., Verma, D. K., Singh, V. K., & Hasan, S. H. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.11.013 · Cited by 63
Akkol, E. K., Orhan, İ. E., & Yeşilada, E. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.09.041 · Cited by 63
Mitochondrial Ferritin: Its Role in Physiological and Pathological Conditions
Levi, S., Ripamonti, M., Dardi, M., Cozzi, A., & Santambrogio, P. (2021) · Cells · doi:10.3390/cells10081969 · Cited by 63
“Experimental results have suggested that there is an interaction between iron metabolism and the metabolism of the β-amyloid protein [68,69].”
BackgroundMetal concentrations and distributions in the human olfactory bulb in Parkinson’s disease
Gardner, B., Dieriks, B. V., Cameron, S., Mendis, L. H. S., Turner, C. P., Faull, R. L. M., & Curtis, M. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-10659-6 · Cited by 66
Salau, V. F., Erukainure, O. L., Ibeji, C. U., Olasehinde, T. A., Koorbanally, N. A., & Islam, M. S. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00099-7 · Cited by 63
Pretorius, E., Vermeulen, N., Bester, J., Lipiński, B., & Kell, D. B. (2013) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.762082 · Cited by 61
Pretorius, E., Bester, J., & Kell, D. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160318 · Cited by 61
“In AD there is also a dramatic increase in brain iron content and in fact there are higher iron concentrations inside the A plaques [80], suggesting that disturbances in brain iron homeostasis may contribute to AD pathogenesis [81, 82].”
BackgroundNeuritic Plaques — Gateways to Understanding Alzheimer’s Disease
Tsering, W., & Prokop, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03736-7 · Cited by 59
“Iron deposition is often associated with aging and neurodegenerative diseases including AD [119–121].”
BackgroundMitochondrial ferritin in neurodegenerative diseases
Yang, H., Yang, M., Guan, H., Liu, Z., Zhao, S., Takeuchi, S., Yanagisawa, D., & Tooyama, I. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.07.005 · Cited by 60
Ma, Q., Song, J., Wang, S., Yang, J., Guo, Y. C., & Dong, C. (2016) · Applied Surface Science · doi:10.1016/j.apsusc.2016.08.039 · Cited by 58
Reaction-based turn-on fluorescent probes with magnetic responses for Fe 2+ detection in live cells
Maiti, S., Aydın, Z., Zhang, Y., & Guo, M. (2015) · Dalton Transactions · doi:10.1039/c4dt03792h · Cited by 59
Interactions of metals and Apolipoprotein E in Alzheimer’s disease
Xu, H. J., Finkelstein, D. I., & Adlard, P. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00121 · Cited by 66
“Iron binding to the hyper-phosphorylated tau protein also facilitates the formation of the NFTs (Altamura and Muckenthaler, 2009) and the iron chelator, deferoxamine (DFO), decreases ironinduced activities of CDK5 and GSK3β and tau phosphorylation (Guo et al.”
BackgroundInfluentialFerroptosis mechanism and Alzheimer's disease
Feng, L., Sun, J. J., Xia, L., Shi, Q., Hou, Y., Zhang, L., Li, M., Fan, C., & Sun, B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389362 · Cited by 62
Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron
Lipiński, B., & Pretorius, E. (2012) · Hematology · doi:10.1179/1607845412y.0000000004 · Cited by 59
Majerníková, N., den Dunnen, W. F. A., & Dolga, A. M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.745046 · Cited by 59
“Imaging and histological experiments support this by showing increased iron deposition in AD-specific brain regions (Altamura and Muckenthaler, 2009; Bush, 2013; Apostolakis and Kypraiou, 2017; Lee and Lee, 2019).”
BackgroundIntranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice
Hanson, L. R., Fine, J. M., Renner, D. B., Svitak, A. L., Burns, R. B., Nguyen, T. M., Tuttle, N. J., Marti, D. L., Panter, S. S., & Frey, W. H. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-011-0050-2 · Cited by 55
“Iron accumulates in the Alzheimer’s brain, and overproduction of ROS or an inability to efficiently regulate ROS in the diseased state may result in the accumulation of tissue damage [16].”
BackgroundKim, S., Stewart, R. J., Park, W.-Y., Jhon, M., Lee, J., Kim, S., Kim, J., Amminger, G. P., Chung, Y., & Yoon, J. (2018) · Nutrients · doi:10.3390/nu10111707 · Cited by 58
Ma, J., Yu, H., Jiang, X., Luo, Z., & Zheng, Y. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.11.039 · Cited by 55
Expression and Localization of Mitochondrial Ferritin mRNA in Alzheimer's Disease Cerebral Cortex
Wang, L., Yang, H., Zhao, S., Sato, H., Konishi, Y., Beach, T. G., Abdelalim, E. M., Bisem, N. J., & Tooyama, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022325 · Cited by 51
“Excessive iron deposition may generate some of the oxidative stress know to occur in AD [4,9,10,11,12].”
BackgroundIron Pathophysiology in Parkinson Diseases
Jiang, H. F., Song, N., Jiao, Q., Shi, L., & Du, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_4 · Cited by 54
A novel fluorescent sensor based on imidazole derivative for Fe3+ ions
Kuzu, B., Tan, M., Ekmekci, Z., & Mengeş, N. (2017) · Journal of Luminescence · doi:10.1016/j.jlumin.2017.08.057 · Cited by 52
Choi, D.-H., Kwon, K.-C., Hwang, D.-J., Koo, J., Um, H.-S., Song, H., Kim, J., Jang, Y., & Cho, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02335-8 · Cited by 53
Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
Pal, A., Cerchiaro, G., Rani, I., Ventriglia, M., Rongioletti, M. C. A., Longobardi, A., & Squitti, R. (2022) · Biomolecules · doi:10.3390/biom12091248 · Cited by 53
“Finally, studies in mouse models have demonstrated that defects in FTH1 (encoding for ferritin), CP, and TFR genes were associated with the typical signs of neurological disorder phenotypes [129].”
BackgroundWong, B. X., & Duce, J. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00081 · Cited by 49
Iron enhances generation of fibrin fibers in human blood: Implications for pathogenesis of stroke
Lipiński, B., Pretorius, E., Oberholzer, H. M., & van der Spuy, W. J. (2012) · Microscopy Research and Technique · doi:10.1002/jemt.22047 · Cited by 55
Weinreb, O., Mandel, S. A., Bar‐Am, O., & Amit, T. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0597-6 · Cited by 53
Cruz, I., Puthongking, P., Cravo, S. M. M., Palmeira, A., Cidade, H. M., Pinto, M. M. M., & Sousa, E. (2017) · Journal of Chemistry · doi:10.1155/2017/8587260 · Cited by 54
“production of reactive oxygen species (ROS) by Fenton reaction, which contribute to the oxidative stress commonly found in AD [58].”
BackgroundJi, C., Steimle, B. L., Bailey, D. K., & Kosman, D. J. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0568-z · Cited by 51
“Iron is an essential co-factor for enzymes involved in a variety of normal neuronal functions (Altamura and Muckenthaler 2009).”
Huang, J., Chen, S., Li, H., Niu, H., Sun, Q., Li, W., Guoqian, T., Li, J., Jin, L., Lyu, J., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.011 · Cited by 52
Uranga, R. M., & Salvador, G. A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2850341 · Cited by 48
“iron nonspecifically coprecipitate with Aβ in AD [50, 97], a”
BackgroundPretorius, E., Pagé, M., Mbotwe, S., & Kell, D. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192121 · Cited by 49
Cozzi, A., Santambrogio, P., Privitera, D., Broccoli, V., Rotundo, L. I., Garavaglia, B., Benz, R., Altamura, S., Goede, J. S., Muckenthaler, M. U., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130315 · Cited by 47
“Localized iron overload is associated with both Alzheimer’s and Parkinson’s disease (Altamura and Muckenthaler, 2009), and with a group of genetic disorders termed neurodegeneration with brain iron accumulation (Hayflick, 2006).”
BackgroundSelf-citationThe regulatory role of heme in neurons
Smith, A. G., Raven, E. L., & Chernova, T. (2011) · Metallomics · doi:10.1039/c1mt00085c · Cited by 45
Xue, X., Gao, M., Rao, H., Luo, M., Wang, H., An, P., Feng, T., Lu, X., Xue, Z., & Liu, X. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.01.049 · Cited by 47
He, L., Kernogitski, Y., Culminskaya, I. V., Loika, Y., Arbeev, K. G., Loiko, E., Bagley, O., Duan, M., Yashkin, A. P., Ukraintseva, S. V., et al. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00179 · Cited by 48
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
Snædal, J., Kristinsson, J. R., Johannesson, & Tórsdóttir, G. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s34729 · Cited by 48
“Iron binding to the hyperphosphorylated tau protein is also a precursory pattern to the formation of the neurofibrillary tangles.(18) Thus, the two most prominent pathological features of the AD brain, plaques and tangles, are dependent on the presence of iron.”
InfluentialHeterogenous distribution of ferroportin-containing neurons in mouse brain
Boserup, M. W., Lichota, J., Haile, D. J., & Moos, T. (2011) · BioMetals · doi:10.1007/s10534-010-9405-2 · Cited by 50
“Its accumulation has been associated with an iron-catalyzed production of free radicals that leads to neuronal damage (Altamura and Muckenthaler 2009; Crichton 2009; Jeong et al. 2009; Rouault and Cooperman 2006; Zecca et al. 2004; Zhu et al. 2007).”
BackgroundShu, R., Zhang, L., Wang, C., Li, N., Wang, H., Xie, K., Yu, Y., & Wang, G. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000562 · Cited by 46
Porras, C. A.-M., & Rouault, T. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094490 · Cited by 45
Lactoferrin: from the structure to the functional orchestration of iron homeostasis
Ianiro, G., Rosa, L., di Patti, M. C. B., Valenti, P., Musci, G., & Cutone, A. (2022) · BioMetals · doi:10.1007/s10534-022-00453-x · Cited by 48
“Normally, alpha pathway is not involved in the generation of amyloid Aβ42, whereas beta pathway is involved in the amyloidogenesis (Altamura and Muckenthaler 2009).”
BackgroundA europium metal–organic framework for dual Fe3+ ion and pH sensing
Rozenberga, L., Skinner, W. M., Lancaster, D. G., Bloch, W. M., Blencowe, A., Krasowska, M., & Beattie, D. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15663-z · Cited by 43
Abdolmohammad‐Zadeh, H., & Zamani-Kalajahi, M. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.02.007 · Cited by 43
Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases
Le, Y., Zhang, Z., Wang, C., & Lu, D. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200731175328 · Cited by 45
Quevenco, F. C., Preti, M. G., van Bergen, J. M. G., Hua, J., Wyss, M., Li, X., Schreiner, S. J., Steininger, S. C., Meyer, R., Meier, I. B., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0249-7 · Cited by 43
“Considering these pathological processes as secondary to the earlier manifestation of AD pathology, they nevertheless may substantially contribute to cognitive decline [4, 81, 90, 91] and may thus represent a correlate of the wellestablished phenomenon of functional disconnection in AD [39, 50, 89].”
BackgroundResultWang, L., Yang, X., Chen, X., Zhou, Y., Lü, X., Yan, C., Xu, Y., Liu, R., & Qu, J. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.11.108 · Cited by 42
Pandya, A., Sutariya, P. G., Lodha, A., & Menon, S. K. (2013) · Nanoscale · doi:10.1039/c3nr33119a · Cited by 41
Patidar, R., Rebary, B., Bhadu, G. R., & Paul, P. (2016) · Journal of Luminescence · doi:10.1016/j.jlumin.2015.12.051 · Cited by 41
Zeinivand, M., Nahavandi, A., & Zare, M. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00665-7 · Cited by 43
Mezzanotte, M., & Stanga, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0094 · Cited by 50
“Despite this, conditions closely related to aging, such as inflammation and BBB damage [49], can be the cause of misdistribution and imbalance of iron in this organ [50, 51].”
Eruygur, N., Uçar, E., Ataş, M., Ergül, M., Ergül, M., & Sözmen, F. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.12.002 · Cited by 40
Ficiarà, E., Munir, Z., Boschi, S., Caligiuri, M. E., & Guiot, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094479 · Cited by 42
“The correlation between brain iron metabolism and neurotoxicity associated with neurodegenerative conditions such as AD remains to be fully elucidated [69], however, much evidence highlighted the involvement of iron in neurodegeneration.”
BackgroundIron Homeostasis in Peripheral Nervous System, Still a Black Box?
Levi, S., & Taveggia, C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5813 · Cited by 41
“PLA2G6, which encodes for a Ca(2 + )-independent phospholipase A(2), is the causative 640 LEVI AND TAVEGGIA”
BackgroundLipiński, B., & Pretorius, E. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00735 · Cited by 42
Association Between Serum Ferritin and Glaucoma in the South Korean Population
Lin, S.-C., Wang, S. Y., Yoo, C., Singh, K., & Lin, S. C. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2876 · Cited by 39
Buduru, P., & Sundara Raja Reddy, B. C. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.06.167 · Cited by 38
Soni, P., Kaidery, N. A., Sharma, S. M., Gazaryan, I. G., Nikulin, S. V., Hushpulian, D. M., & Thomas, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1390798 · Cited by 38
“On the other hand, iron is an inductor for furin, which reduces the activation of α -secretase, which leads to the activation of β - secretase and contributes to amyloid plaque production (Hwang et al., 2006; Altamura and Muckenthaler, 2009).”
BackgroundIron metabolism in diabetes-induced Alzheimer’s disease: a focus on insulin resistance in the brain
Chung, J. Y., Kim, H.-S., & Song, J. (2018) · BioMetals · doi:10.1007/s10534-018-0134-2 · Cited by 40
Astrocytes retain their antioxidant capacity into advanced old age
Liddell, J. R., Robinson, S. R., Dringen, R., & Bishop, G. M. (2010) · Glia · doi:10.1002/glia.21024 · Cited by 37
Yan, S.-Q., Sun, J.-Z., Yan, Y.-Q., Wang, H., & Lou, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031748 · Cited by 35
Pitz Jacobsen, D., Fjeldstad, H. E., Johnsen, G. M., Fosheim, I. K., Moe, K., Alnæs-Katjavivi, P., Dechend, R., Sugulle, M., & Staff, A. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791606 · Cited by 36
Pretorius, L., Kell, D. B., & Pretorius, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00851 · Cited by 36
“, 1991), and many reviews point to the role of poorly liganded iron in AD development (Exley, 2006; Castellani et al., 2007, 2012; Kell, 2009, 2010; Sandro and Muckenthaler, 2009; Grunblatt et al., 2011; Weinreb et al., 2011; Peters et al., 2015; Wood, 2015; Belaidi and Bush, 2016).”
BackgroundKupershmidt, L., & Youdim, M. B. H. (2023) · Cells · doi:10.3390/cells12050763 · Cited by 38
Zhang, H.-Y., Song, N., Jiang, H. F., Bi, M., & Xie, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.09.010 · Cited by 39
Orhan, İ. E., Süntar, I. P., & Akkol, E. K. (2011) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2011.585964 · Cited by 36
“As oxidative stress and iron dysregulation are associated with progress of AD (Altamura and Muckenthaler 2009), antioxidant activity of the extracts was also assessed by eight in-vitro assays; namely radical scavenging activity against 2,2-diphenyl-1-picrylhydrazyl (DPPH),…”
MethodDjahed, B., Kermani, M., Farzadkia, M., Taghavi, M., & Norzaee, S. (2020) · Journal of Environmental Health Science and Engineering · doi:10.1007/s40201-020-00539-z · Cited by 35
Sarkar, D., Chowdhury, M., & Das, P. K. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02450c · Cited by 35
PP2A–AMPKα–HSF1 axis regulates the metal-inducible expression of HSPs and ROS clearance
Zhu, X., Chen, L., Bai, Q., Ma, L., Li, D., Zhang, J.-M., Gao, C., Lei, Z., Zhang, Z., Xing, X., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.002 · Cited by 37
Sleep Disorders in Parkinson’s Disease: Clinical Features, Iron Metabolism and Related Mechanism
Yu, S., Sun, L. Z., Liu, Z., Huang, X., Zuo, L., Cao, C.-J., Zhang, W., & Wang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082924 · Cited by 37
“Pathology and autopsy studies observed excessive iron deposition in substantia nigra, with total iron elevated by 25% to 100% and iron ions by 225% [14,15].”
BackgroundAutosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis
Naseri, N. N., Sharma, M., & Velinov, M. T. (2020) · Clinical Genetics · doi:10.1111/cge.13829 · Cited by 34
“concordance with previous studies of the role of iron in neurodegenerative disorders.(60) Therefore, therapy with iron chelators that efficiently cross the blood-brain barrier, may be of future consideration.”
van Vuuren, M. J., Nell, T. A., Carr, J. A., Kell, D. B., & Pretorius, E. (2020) · Biomolecules · doi:10.3390/biom11010030 · Cited by 40
Imatinib and spironolactone suppress hepcidin expression
Mleczko‐Sanecka, K., da Silva, A. R., Call, D., Neves, J. C., Schmeer, N., Damm, G., Seehofer, D., & Muckenthaler, M. U. (2017) · Haematologica · doi:10.3324/haematol.2016.162917 · Cited by 34
“Furthermore, alterations of iron levels or its misdistribution exacerbates pathologies of common acquired diseases such as chronic liver disease,(4) diabetes,(5) cardiovascular disease or neurodegenerative disorders.(6) Conversely, the anemia of inflammation”
Self-citationSabbir, M. G. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00099 · Cited by 39
“While the mechanism for the brain iron accumulation in these disorders is unknown, it correlates with the production of ROS and oxidative damage that hallmark these neurodegenerative disorders (Altamura and Muckenthaler, 2009).”
BackgroundInfluentialMetal Ions in Alzheimer's Disease Brain
Sastre, M., Ritchie, C. W., & Hajji, N. (2015) · Cited by 44
A role for p53 in mitochondrial stress response control of longevity in C. elegans
Torgovnick, A., Schiavi, A., Testi, R., & Ventura, N. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.02.007 · Cited by 34
“Moreover, altered ISC-proteins’ biogenesis and function lead to misregulated iron concentration and availability (Altamura and Muckenthaler, 2009) thus activating distinct intracellular responses (Le and Richardson, 2002).”
BackgroundSyal, A., & Sud, D. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.03.104 · Cited by 33
Increase in brain atrophy after subdural hematoma to rates greater than associated with dementia
Zahid, A. B., Balser, D. Y., Thomas, R., Mahan, M. Y., Hubbard, M. E., & Samadani, U. (2018) · Journal of neurosurgery · doi:10.3171/2017.8.jns17477 · Cited by 32
Li, J., Nguyen, T. D., Zhang, Q., Guo, L., & Wang, Y. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28092 · Cited by 32
“Increased brain iron deposition in the deep gray matter (GM) is a pathological hallmark of many age-related neurodegenerative disorders,(8) which is thought to promote oxidative stress and cause neuronal death.(9) The emergence of quantitative susceptibility mapping (QSM) technique over the past decade(10) has enabled…”
BackgroundFluorescence determination of Fe( iii ) in drinking water using a new fluorescence chemosensor
Khairy, G. M., Amin, A. S., Moalla, S. M. N., Medhat, A., & Hassan, N. Y. (2022) · RSC Advances · doi:10.1039/d2ra05144c · Cited by 31
Cui, F., Sun, J., Yang, X., Ji, J., Pi, F., Zhang, Y., Lei, H., & Sun, X. (2019) · The Analyst · doi:10.1039/c9an00968j · Cited by 31
Marell, P. S., Blohowiak, S. E., Evans, M. D., Georgieff, M., Kling, P. J., & Tran, P. V. (2019) · Nutrients · doi:10.3390/nu11102478 · Cited by 31
“In line with this concept, the function of α-secretase, another enzyme that cleaves β-APP, is modulated by furin, an iron-dependent enzyme [43].”
BackgroundShalabalija, D., Mihailova, L., Crcarevska, M. S., Karanfilova, I. C., Ivanovski, V., Nestorovska, A. K., Novotni, G., & Dodov, M. G. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102434 · Cited by 34
Stable iron isotope tracing reveals significant brain iron uptake in adult rats
Chen, J., Shahnavas, S., Singh, N. N., Ong, W.-Y., & Walczyk, T. (2012) · Metallomics · doi:10.1039/c2mt20226c · Cited by 32
Sruthi, S. N., Maurizi, L., Nury, T., Sallem, F., Boudon, J., Riedinger, J., Millot, N., Bouyer, F., & Lizard, G. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.06.041 · Cited by 33
Neuropathology of Parkinson’s Disease
Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 35
“nuclear RNA defi cits, protein–iron and neuromelanin–iron interactions [ 87 , 89 , 91 , 367 , 368 ], transcriptional α-syn dysregulation [ 152 ], disorders of calcium homeostasis, prion-like behavior of misfolded proteins [ 200 , 369 , 370 ], excitotoxicity from increased glutamatergic input, neuroinfl ammation [ 45 ,…”
BackgroundTian, S., Wang, B., Ding, Y., Zhang, Y. L., Yu, P., Chang, Y.-Z., & Gao, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117419 · Cited by 32
Ferroptosis: a potential therapeutic target for Alzheimer’s disease
Yang, L., & Nao, J. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0121 · Cited by 32
Bamm, V. V., & Harauz, G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1570-y · Cited by 30
Iron loading and oxidative stress in theAtm−/−mouse liver
McDonald, C. J., Ostini, L., Wallace, D. F., John, A. N., Watters, D. J., & Subramaniam, V. N. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00486.2010 · Cited by 32
Orhan, İ. E., & Akkol, E. K. (2011) · Food Research International · doi:10.1016/j.foodres.2011.01.037 · Cited by 35
Gao, Y., Liang, C., Zhang, Q., Zhuang, H., Sui, C., Zhang, N., Feng, M., Xin, H., Guo, L., & Wang, Y. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01638-x · Cited by 30
“The accumulation of iron in the deep GM of the brain is a well-recognized pathological hallmark of several neurodegenerative disorders associated with advanced age [9, 10].”
Zhang, L., & Du, J. (2016) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2016.01.012 · Cited by 29
Kim, S., Yadav, D., Kim, S., Kim, J., & Cho, K. (2017) · Nutrients · doi:10.3390/nu9070690 · Cited by 28
Zhang, L., Xiao, H., Xing, Y., & Deng, Y. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108302 · Cited by 28
Wang, Y., Jian, J., Sun, B., Wei, Y., Pan, D., Cao, J., & Shen, Y. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132413 · Cited by 28
Chen, J., Singh, N. N., Tay, H., & Walczyk, T. (2014) · Metallomics · doi:10.1039/c4mt00054d · Cited by 28
Insight into the Double-Edged Role of Ferroptosis in Disease
Zhang, L., Jia, R., Li, H., Yu, H., Ren, K., Jia, S., Li, Y., & Wang, Q. (2021) · Biomolecules · doi:10.3390/biom11121790 · Cited by 29
“A significant increase in iron levels in the brains of people with AD presents the possibility of ferroptosis [79].”
BackgroundGeorgiev, M. I., Alipieva, K. I., & Orhan, İ. E. (2011) · Phytotherapy Research · doi:10.1002/ptr.3555 · Cited by 31
Evaluating the Role of CXCR3 in Pain Modulation: A Literature Review
Aloyouny, A. Y., Bepari, A., & Rahman, I. (2020) · Journal of Pain Research · doi:10.2147/jpr.s254276 · Cited by 26
“CNS iron overload, mediated by iron-responsive element-negative divalent metal transporter 1 (IRE(-)DMT1), initiates neuroinflammatory damage and has been associated with several neurodegenerative diseases.(40,41) Also, RIH was associated with Aloyouny et al Dovepress”
BackgroundFeng, J., She, Y., Li, C., & Shen, L. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.103009 · Cited by 26
Xu, H., Jiang, H. F., & Xie, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00071 · Cited by 29
“Studies also showed that iron accumulation was observed in the hippocampus and cerebral cortex in AD patients (Piñero et al., 2000, 2001; Altamura and Muckenthaler, 2009).”
Background
Metadata
- Authors
- Altamura, S., & Muckenthaler, M. U.
- Affiliations
- University Hospital Heidelberg (DE)
- Corresponding author
- Muckenthaler, Martina U.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-04-17
- Volume
- 16
- Issue
- 4
- Pages
- 879-895
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1785761853
- Cited by
- 369
- References
- 190
- Citations by year
- 2026: 5 · 2025: 15 · 2024: 13 · 2023: 17 · 2022: 26 · 2021: 22 · 2020: 25 · 2019: 28 · 2018: 26 · 2017: 22 · 2016: 22 · 2015: 16 · 2014: 30 · 2013: 23 · 2012: 19
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Baden-Württemberg Stiftung
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron toxicity, brain iron accumulation
- MeSH terms
- Aging, Alzheimer Disease, Animals, Brain, Humans, Iron, Parkinson Disease, Oxidative Stress, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.